acrisorcin
Trade name: akrinol
Small moleculeapproved
Approved
Jun 1, 1966
Acrisorcin is a topical anti-infective typically used as a fungicide. It is a combination of the active ingredients 9-aminoacridine and 4-hexylresorcinol. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1960s
- Jun 1, 1964
Schering-Plough — First NDA Organization
- Jun 1, 1964
Schering-Plough — NDA Organization
- Jun 1, 1966
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Unknown
Approval history
- approvedJun 1, 1966
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCC1=C(O)C=C(O)C=C1.NC2=C3C=CC=CC3=NC4=CC=CC=C24- Mol. weight
- 388.502 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Discontinued
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaAcrisorcin ↗
- NCATS2U918O4BEV ↗
- ChEMBLCHEMBL1201038 ↗
Also known as
- acrisorcin
- acrisorcin
- acrisorcin
- acrisorcin
- acrisorcin
- acrisorcin
- akrinol
- akrinol
- akrinol
- akrinol
- sch-7056
- sch-7056
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Schering | For profit | NDA2 | — |
| Schering-Plough | For profit | NDA | Jun 1, 1964 |